Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature. - Concepedia

Concepedia

Publication | Closed Access

Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.

104

Citations

25

References

2006

Year

Bernard M. Tijink, Dario Neri, C. René Leemans, Marianne Budde, Ludger M. Dinkelborg, Marijke Stigter‐van Walsum, Luciano Zardi, Guus A.M.S. van Dongen

Abstract

RIT with 131I-L19-SIP appeared efficacious in HNSCC xenografts. The efficacy of RIT was enhanced by combination with cetuximab, without increase of toxicity.

References

	Year	Citations

Page 1